Radboud University Medical Center

🇳🇱Netherlands

Country: 🇳🇱Netherlands

Ownership: Private

Established: 1951-01-01

Employees: -

Market Cap: -

Website: http://www.radboudumc.nl

Clinical Trials

Safety and Protective Efficacy of BCG Vaccination Against Controlled Human Malaria Infection

Phase 2

Completed

Conditions: Malaria
Plasmodium Falciparum

Interventions: Biological: BCG vaccination

First Posted Date: 2016-02-26

Last Posted Date: 2017-04-20

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 20

Registration Number: NCT02692963

Locations: 🇳🇱
Radboud university medical center, Nijmegen, Netherlands

Withdrawal of Inhaled Corticosteroids in Primary Care Patients With COPD

Not Applicable

Conditions: Pulmonary Disease, Chronic Obstructive

Interventions: Other: ICS withdrawal
Other: Usual care

First Posted Date: 2016-02-25

Last Posted Date: 2016-02-25

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 620

Registration Number: NCT02691988

Locations: 🇳🇱
Radboud University Medical Centre, Department of Primary and Community Care, Nijmegen, Netherlands

Effects of Vasopressors on Immune Response

Phase 4

Completed

Conditions: Endotoxemia

Interventions: Drug: Vasopressins
Drug: Placebo
Drug: Norepinephrine
Drug: Phenylephrine

First Posted Date: 2016-02-05

Last Posted Date: 2016-10-13

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 40

Registration Number: NCT02675868

Locations: 🇳🇱
Radboudumc, Nijmegen, Gelderland, Netherlands

Pharmacokinetics of Fluconazole IV as Prophylaxis or Therapy to ICU Patients

Completed

Conditions: Candidiasis

First Posted Date: 2016-01-28

Last Posted Date: 2020-12-07

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 20

Registration Number: NCT02666716

Locations: 🇳🇱
Canisius Wilhelmina Ziekenhuis, Nijmegen, Netherlands
🇳🇱
Radboud university medical center, Nijmegen, Netherlands
🇳🇱
University Medical Center Utrecht, Utrecht, Netherlands

The Effects of Preceding LPS Administration on the Fluenz-induced Immune Response

Not Applicable

Completed

Conditions: Innate Immune Response
Immune Tolerance

Interventions: Biological: Fluenz
Other: placebo
Other: LPS

First Posted Date: 2015-12-30

Last Posted Date: 2019-05-14

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 30

Registration Number: NCT02642237

PK/PD of EA-230 During Endotoxemia

Phase 1

Completed

Conditions: Endotoxemia
Systemic Inflammatory Response

Interventions: Drug: EA-230
Drug: Endotoxin
Drug: Placebo

First Posted Date: 2015-12-14

Last Posted Date: 2016-06-23

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 60

Registration Number: NCT02629874

Locations: 🇳🇱
Intensive care, research unit, Radboud University Medical Centre, Nijmegen, Gelderland, Netherlands

Reflectance Confocal Microscopy in Basal Cell Carcinoma

Not Applicable

Completed

Conditions: Carcinoma, Basal Cell

Interventions: Device: Reflectance confocal microscopy
Procedure: Punch biopsy
Procedure: Surgical excision

First Posted Date: 2015-12-07

Last Posted Date: 2019-09-20

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 288

Registration Number: NCT02623101

Locations: 🇳🇱
Canisius Wilhelmina Hospital, Nijmegen, Netherlands
🇳🇱
Radboud University Medical Center, Nijmegen, Netherlands
🇳🇱
Rijnstate Hospital, Velp, Netherlands

Ticagrelor in Human Endotoxemia Response to Human Endotoxemia

Not Applicable

Completed

Conditions: Endotoxemia

Interventions: Drug: ticagrelor
Drug: Placebo
Drug: Clopidogrel
Drug: Acetylsalicylic acid lysinate

First Posted Date: 2015-11-23

Last Posted Date: 2015-12-15

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 40

Registration Number: NCT02612480

Locations: 🇳🇱
Intensive Care Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, Gelderland, Netherlands

A Trial Comparing Deep Versus Moderate Neuromuscular Block - in Low Pressure Pneumoperitoneum

Phase 4

Completed

Conditions: Pneumoperitoneum
Observation of Neuromuscular Block
Nephrostomy; Complications

Interventions: Other: Deep neuromsucular block

First Posted Date: 2015-11-11

Last Posted Date: 2016-04-04

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 34

Registration Number: NCT02602964

Locations: 🇳🇱
Radboud University Medical Center, Nijmegen, Netherlands

Tight Control Dose Reductions of Biologics in Psoriasis Patients With Low Disease Activity

Phase 4

Completed

Conditions: Psoriasis

Interventions: Other: Dose decrease
Other: Usual care

First Posted Date: 2015-11-11

Last Posted Date: 2019-04-01

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 120

Registration Number: NCT02602925

Locations: 🇳🇱
ZGT hospital, Almelo, Netherlands
🇳🇱
Gelre hospitals, Apeldoorn, Netherlands
🇳🇱
Slingeland Hospital, Doetinchem, Netherlands

and more 3 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy